SCHEMBL23906396

SCHEMBL23906396

CCOC(=O)CN1CCC2(CC(OI)C2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.33
HSD11B1 P28845 1/20 0.33
KDM4E B2RXH2 6/20 0.33
ALDH1A1 P00352 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GSK3B P49841 2/20 0.32
GSK3A P49840 1/20 0.32
OPRM1 P35372 2/20 0.32
OPRD1 P41143 2/20 0.32
OPRK1 P41145 2/20 0.32
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALOX12 P18054 1/20 0.31
CYP2C19 P33261 1/20 0.31
PKM P14618 1/20 0.31
ATM Q13315 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25477020 0.84 KDM4E (0.34) ELANEHSD11B1KDM4EALDH1A1TDP1
SCHEMBL14671150 0.82 ELANE (0.40) ELANEHSD11B1KDM4EALDH1A1GSK3B
SCHEMBL23906394 0.81 ITGB3 (0.37) HSD17B10
SCHEMBL14671148 0.80 KDM4E (0.39) ELANEKDM4EALDH1A1GSK3BGSK3A
SCHEMBL14671169 0.76 ELANE (0.42) ELANEKDM4EALDH1A1GSK3BGSK3A
SCHEMBL25546858 0.76 ELANE (0.37) ELANEHSD11B1KDM4EALDH1A1TDP1
SCHEMBL30148862 0.74 TSHR (0.38) ELANEKDM4EALDH1A1TDP1LMNA
SCHEMBL14671159 0.73 KDM4E (0.40) ELANEKDM4EALDH1A1TDP1GSK3B
SCHEMBL29324709 0.72 KDM4E (0.44) ELANEHSD11B1KDM4EALDH1A1TDP1
SCHEMBL12635472 0.72 ELANE (0.39) ELANEHSD11B1KDM4EALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021203025-A1 1 H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1 H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-10-07 WO disclosed